Literature DB >> 4945738

Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

T Godal, B Myklestad, D R Samuel, B Myrvang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4945738      PMCID: PMC1713129     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  24 in total

1.  Immunologic reactivity in patients with leprosy.

Authors:  J N Sheagren; J B Block; J R Trautman; S M Wolff
Journal:  Ann Intern Med       Date:  1969-02       Impact factor: 25.391

2.  Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice.

Authors:  J M Gaugas
Journal:  Nature       Date:  1968-12-21       Impact factor: 49.962

Review 3.  The mechanism of immunological paralysis.

Authors:  D W Dresser; N A Mitchison
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

4.  A micro-incubation chamber technique for testing the immunological activity of cultured lymphocytes.

Authors:  J O Lamvik
Journal:  Scand J Haematol       Date:  1968

5.  Experimental lepromatous leprosy.

Authors:  R J Rees; M F Waters; A G Weddell; E Palmer
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

6.  Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients.

Authors:  R E Dierks; C C Shepard
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

7.  Leprosy and genetics. A review of past research with remarks concerning future investigations.

Authors:  B Beiguelman
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

8.  Immunological tolerance and inhibition by hapten.

Authors:  J L Boak; E Kölsch; N A Mitchison
Journal:  Antibiot Chemother       Date:  1969

9.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

10.  The influence of immunologically committed lymphoid cells on macrophage activity in vivo.

Authors:  G B Mackaness
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307

View more
  63 in total

Review 1.  Suppression of the immune response by microorganisms.

Authors:  J H Schwab
Journal:  Bacteriol Rev       Date:  1975-06

2.  Alterations of the immune response associated with chronic experimental leishmaniasis.

Authors:  B Arredondo; H Pérez
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

3.  Dermal exudate macrophages. Induction in dermal chambers and response to lymphokines.

Authors:  M Goihman-Yahr; M Ulrich; A Noya-León; A Rojas; J Convit
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

4.  Galectin-3 regulates the innate immune response of human monocytes.

Authors:  Andrew W Chung; Peter A Sieling; Mirjam Schenk; Rosane M B Teles; Stephan R Krutzik; Daniel K Hsu; Fu-Tong Liu; Euzenir N Sarno; Thomas H Rea; Steffen Stenger; Robert L Modlin; Delphine J Lee
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

5.  Amyloid fibril protein AA in Papua New Guinean amyloidosis.

Authors:  R F Anders; M A Price; I S Wilkey; G Husby; F Takitaki; J B Natvig; K P McAdam
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

6.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Amyloid-related serum component (protein ASC) IN LEPROSY PATIENTS.

Authors:  G Kronvall; G Husby; D Samuel; G Bjune; H Wheate
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

9.  Potentiation of schistosome granuloma formation. By lentinan--a T-cell adjuvant.

Authors:  J E Byram; A Sher; J DiPietro; F von Lichtenberg
Journal:  Am J Pathol       Date:  1979-02       Impact factor: 4.307

10.  Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.

Authors:  G Bjune; R S Barnetson; D S Ridley; G Kronvall
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.